4//SEC Filing
Lukatch Heath 4
Accession 0001415889-24-002320
CIK 0001649094other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:40 PM ET
Size
8.5 KB
Accession
0001415889-24-002320
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Lukatch Heath
Director
Transactions
- Sale
Common Stock
2024-01-31$71.50/sh−5,000$357,500→ 5,625 total - Exercise/Conversion
Stock Option (right to buy)
2024-01-31−5,000→ 6,000 totalExercise: $16.00Exp: 2030-06-10→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2024-01-31$16.00/sh+5,000$80,000→ 10,625 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2023.
- [F2]Fully vested and exercisable.
Documents
Issuer
Vaxcyte, Inc.
CIK 0001649094
Entity typeother
Related Parties
1- filerCIK 0001596385
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 4:40 PM ET
- Size
- 8.5 KB